Login to Your Account

Regulatory NEWS

PERTH, Australia – Australia will save nearly A$500 million (US$379 million) over the next four years due to a deal hammered out by the federal government and pharmaceutical industry stakeholders.

HONG KONG – In a country where just seven new oncology drugs were introduced in the last five years, the recent approval of Apac Biotech Pvt. Ltd.'s first-of-its-kind autoimmune therapy marked a significant step forward.

A spate of bills ranging from spurring generic competition to funding pediatric research was introduced last week just before the U.S. Congress turned the lights out for a two-week recess.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: